Connie Lehman, MD, PhD, chief of breast imaging, co-director of the Avon Comprehensive Breast Evaluation Center at the Massachusetts General Hospital, discusses the challenges of the COVID-19 pandemic on breast screenings, increased cancer rates and issues with the vaccines causing false positives on mammograms.

Connie Lehman, MD, PhD, chief of breast imaging, co-director of the Avon Comprehensive Breast Evaluation Center at the Massachusetts General Hospital, explains why she thinks contrast-enhanced mammography will likely become the go-to supplemental imaging modality for women with dense breasts.

"As the prevalence of females with tattoos increases, tattoo pigment needs to be considered as a potential differential diagnosis of breast calcification,” experts involved in the research suggested.

Connie Lehman, MD, chief of breast imaging, co-director of the Avon Comprehensive Breast Evaluation Center at Massachusetts General Hospital, discusses how artificial intelligence (AI) is being implemented in breast imaging.

These patients are at greatest risk of developing lung metastases within three months of surgery.

Society of Breast Imaging President John Lewin, MD, explains some of the new initiatives and technology in mammography that are designed to increase early breast cancer detection.

Compared to USPSTF 2013,  modified eligibility criteria could increase cancer detection by 37%.

Breast cancer screenings present an additional opportunity to identify more women who would also qualify for lung cancer screening, authors of a new paper in JAMA said.